Private Healthcare Fund IV Lp Cormorant serves as Executive at MoonLake Immunotherapeutics, where they oversee executive responsibilities. Since joining the company, Private Healthcare Fund IV Lp Cormorant has executed 3 insider transactions totaling $16.8M, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 4, 2023 involved purchasing 67,814 shares valued at $3.9M.
Private Healthcare Fund IV Lp Cormorant currently holds 8,435,312 shares of MoonLake Immunotherapeutics (MLTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Private Healthcare Fund IV Lp Cormorant has been a net buyer of MLTX stock. They have purchased $16.8M and sold $0 worth of shares.
Private Healthcare Fund IV Lp Cormorant's most recent insider trade was on Oct 4, 2023, when they purchased 67,814 shares at $57.32 per share.
Get notified when new Form 4 filings are submitted
| $57.25 |
| Discretionary |
| Oct 2, 2023 | MLTX | $4.3M | Purchase | 74,911 | $57.37 | Discretionary |